A retrospective survey, based on a standardized questionnaire sent to qualified public health experts in tuberculosis in 50 European countries, was carried out to evaluate the following: concordance between national vaccination programmes and WHO recommendations on BCG vaccination for prevention of tuberculosis; relation between BCG vaccination and revaccination policy and the tuberculosis epid...

Methods of economic evaluation, especially cost-effectiveness analysis and cost-benefit analysis, are widely used to examine new healthcare technologies. However, few economic evaluations of pharmacogenomics have been conducted, and pharmacogenomic researchers may be unfamiliar with how to review or conduct these analyses. This review provides an overview of the methods of economic evaluation a...

human papilloma virus (hpv) vaccine recently has been added to the iran drug list, decision makers need information beyond that available from rcts to recommend funding for this vaccination program to add it to the national immunization program in iran. modeling and economic studies have addressed some of those information needs in foreign countries. in order to determine the long term benefit ...

    Background: Economic evaluation of subcutaneous immunoglobulin therapy (SCIG) is important, and it has recently been used for treatment of patients with primary immunodeficiency (PID) diseases, and can improve allocation of resources in health care systems. The present research aimed at providing an economic assessment of SCIG and IVIG (intravenous immunoglobulin therapy) adm...

Incremental or marginal cost-effectiveness ratios are founded on a number of assumptions that weaken their suitability as a way to balance competing economic and clinical priorities. We therefore propose a more relevant and responsible way to gauge the impact of clinical management strategies based on “consumer protection” principles— explicit disclosure of (1) the total magnitude of expected b...

These modes of analysis [cost-effectiveness and cost-benefit] are neither good for nothing nor good for everything, and one cannot speak of them as wholly good or bad. It is much more useful to try to specify some conditions under which they would or would not be helpful for various purposes.

background: anemia is the most common blood disorder observed in vulnerable groups and affects their efficiency in their everyday activities. possible complications of the disease may be reduced or prevented by screening of patients. screening programs impose certain costs upon the health system, which may offset their positive effects. whether the positive impacts of screening outweigh its cos...

breast cancer is the leading cause of malignancy among women. screening using mammography is proposed as an effective intervention for reducing early deaths due to breast cancer. we conducted a systematic review to assess the cost-effectiveness of such screening programs. we searched medline, scopus and google scholar and complemented it by other searches using sensitive search terms from 1993-...

BACKGROUND The Alberta Project Promoting active Living and healthy Eating in Schools (APPLE Schools) has been recognized as a "best practice" in preventing childhood obesity. To inform decision making on the economic implications of APPLE Schools and to justify investment, we evaluated the project's cost-effectiveness following a life-course approach. METHODS We developed a state transition m...

background: economic evaluation includes evaluation of costs and benefits of screening. one of the economic evaluation methods is cost-effectiveness analysis. the aim of this study was cost-effectiveness analysis of type 2 diabetes screening in shiraz, iran.   methods: the target population of this cross-sectional study consisted of all shiraz population over 30 years old. a total of 171067 per...